Cancer incidence and mortality in Bucaramanga, Colombia. 2008-2012
Abstract
Introduction: Cancer is a huge burden worldwide, especially for the least developed countries. Population-based cancer registries (PBCRs) are essential to know the cancer territorial profiles and the evaluation of the impact of their control programs.Aim: To estimate the cancer incidence and mortality in the Metropolitan Area of Bucaramanga over the period 2008-2012.
Methods: A descriptive study of cancer incidence and mortality was conducted in the Metropolitan Area of Bucaramanga. The cases of primary invasive cancer from the period 2008-2012 were obtained from the base of the Population Registry of Cancer of the Metropolitan Area of Bucaramanga. The National Administrative Department of Statistics provided population and death data. Crude rates of global and specific incidence and mortality were estimated for each sex, and standardized incidence and mortality rates.
Results: During the five-year period, 8,775 incidents cases of cancer were recorded (excluding non-melanoma skin cancer). The global standardized incidence rate was 151.7 per 100,000 men-year and 157.2 per 100,000 women-year. The main locations were prostate, stomach and colorectal men in men, and breast, thyroid and colorectal in women. The standardized mortality rate by sex was 94.8 per 100,000 men-year and 78.0 per 100,000 women-year.
Conclusion: For the most part of neoplasms, the incidence and mortality rates in the Metropolitan Area of Bucaramanga are lower than the rates reported in Colombia and Metropolitan Area of Bucaramanga in the five-year period 2003-2007, except for colorectal cancer, thyroid cancer and leukemia showing a tendency to increase, which requires further investigation.
Authors
Downloads
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.
Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45.
Wilson L, Bhatnagar P, Townsend N. Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: joinpoint regression analysis. Popul Health Metr. 2017;15(1):23.
Organización Mundial de la Salud. Programas Nacionales de Control del Cáncer. Organización Mundial de la Salud; 2004.
WHO. National Cancer Control Programmes: Policies and managerial guidelines. World Health Organization. 2002;1:1–180.
Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, et al. Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. BMC Cancer. 2012;12(1):11.
Parkin DM, Bray F. Evaluation of data quality in the cancer registry: Principles and methods Part II. Completeness. Eur J Cancer. 2009;45(5):756–64.
Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-. Foucher E, Swaminathan R, Ferlay J, editors. Cancer Incidence in Five Continents, Vol. X. IARC. Scientific Publication 1o. 164. Lyon: International Agency for Research on Cancer; 2014.
Shin HR, Curado MP, Ferlay J, Heanue M, Edwards B, Storm H. Chapter 5: Comparability and quality of data. Consultado: noviembre 2 de 2017. Disponible en : http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-5.pdf
Ospina ML, Huertas JA, Montaño JL, Rivillas JC. Observatorio Nacional de Cáncer Colombia. Rev Fac Nac Salud Pública. 2015;33(2):262–176.
Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102–11.
Ministerio de Salud y Protección Social, Instituto Nacional de Cancerología. Plan Nacional para el control del Cáncer en Colombia. 2012-2020. Bogotá: Ministerio de Salud y Protección Social; 2012
Corporación Autónoma Nacional para la Defensa de la Meseta de Bucaramanga. Área de Jurisdicción. Consultado: noviembre 2 de 2017. Disponible en: http://www.cdmb.gov.co/web/asi-es-la-cdmb/area-de-jurisdiccion
DANE. Series de población. Consultado: noviembre 2 de 2017. Disponible en: http://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/series-de-poblacion.
WHO. ICD-O-3 First Revision. Consultado: noviembre 2 de 2017. Disponible en: http://apps.who.int/iris/bitstream/10665/96612/1/9789241548496_eng.pdf
Curado MP, Okamoto N, Ries L, Sriplung H, Young J, Carli PM, et al. International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev. 2005;14(4):307–8.
Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. Cancer registration: principles and methods. Int Agency Res Cancer. 1991.
WHO. ICD-10 Transition. Fam Pract Manag. 2011;18:39.
IACR - Software for cancer registries. Consultado: noviembre 2 de 2017. Disponible en: http://www.iacr.com.fr/index.php?option=com_content&view=category&id=68&Itemid=445.
CDC - Cancer - NPCR - Registry Plus Link Plus. Consultado: noviembre 2 de 2017. Available from: https://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm.
Boniol M, Heanue M. Age-standardisation and denominators. In: Curado MP, Shin B, Storm HR, Ferlay J, Heanue M, Boyle P (eds). Cancer Incidence in five continents, Vol. IX. Lyon: International Agency for Research on Cancer; 2007. pp. 99-101. Disponible en: http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-7.pdf
StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015.
International Agency for Research on Cancer. CanReg5. 2014.
Uribe CJ, Osma S, Herrera V. Cancer incidence and mortality in the Bucaramanga metropolitan area, 2003-2007. Colomb Med (Cali). 2012;43(4):290–7.
Bray F, Colombet M, Mery L, Piñeros M, Znaor A, Zanetti R et al. CI5 XI - Home; 2017.
Sierra MS, Soerjomataram I, Antoni S, Laversanne M, Piñeros M, de Vries E, et al. Cancer patterns and trends in Central and South America. Cancer Epidemiol. septiembre de 2016;44:S23–42.
Ministro de Salud y Protección Social. Quinto Informe ONS: carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia. Imprenta Nacional de Colombia, Bogotá, DC.; 2015.
Hormiga CM, León MH, Otero JA, Rodríguez LA. Factores de riesgo para enfermedades crónicas en Santander. Método STEPwise. 1a ed. Bucaramanga: Secretaría de Salud de Santander, Observatorio de Salud Pública de Santander; 2010.
Hormiga Sánchez CM, Alzate Posada ML, Borrell C, Palència L, Rodríguez Villamizar LA, Otero Wandurraga JA, et al. Actividad física ocupacional, de transporte y de tiempo libre: Desigualdades según género en Santander, Colombia. Rev Salud Pública. 2016;18(2):201–13.
Hormiga CM. Influencia del género en la práctica regular de actividad física en Santander, Colombia. Tesis doctoral. Universidad Nacional de Colombia. 2015. Disponible en: http://www.bdigital.unal.edu.co/52823/
Álvarez LS. Los estilos de vida en salud: del individuo al contexto. Rev Fac Nac Salud Pública. 2012;30(1):95–101.
De Vries E, Uribe C, Pardo C, Lemmens V, Van de Poel E, Forman D. Gastric cancer survival and affiliation to health insurance in a middle-income setting. Cancer Epidemiol. 2015;39(1):91–6.
Mantilla-villabona LY, Ospina-galeano DC, Maturana-martínez DMA. Barreras para la atención en salud durante el diagnóstico y tratamiento del cáncer gástrico. 2017;19(3):211–20.
Copyright (c) 2018 Revista Colombia Medica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use
